Phase IV

Phase IV clinical trials, also known as post-marketing surveillance studies, are conducted after a drug has been approved and is on the market. These trials continue to monitor the drug’s safety, efficacy, and long-term effects in a larger, more diverse patient population. Phase IV studies can identify rare or long-term side effects and provide additional information on the drug’s optimal use.

Back to Glossary